A Phase II Trial of Bendamustine, Carboplatin and Dexamethasone (BCD) for Refractory or Relapsed Peripheral T-Cell Lymphoma (BENCART): A Consortium for Improving Survival of Lymphoma (CISL) Trial
Year: 2016
Type: article
Study design: Clinical Trial
Source: Blood
Institutions: Hanyang University, Samsung Medical Center, Sungkyunkwan University, Asan Medical Center, University of Ulsan, Soonchunhyang University, Chonnam National University Hwasun Hospital, Keimyung University Dongsan Medical Center, Inje University, The Catholic University of Korea St. Vincent's Hospital, Yeungnam University Medical Center, Ulsan University Hospital, Seoul National University Hospital
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2596184540